v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 29, 2024   1,913,768,000        
Beginning balance at Dec. 29, 2024 $ 9,668 $ 19 $ 16,130 $ (242) $ (93) $ (6,146)
Beginning balance (in shares) at Dec. 29, 2024       11,208,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 742       742  
Other comprehensive loss 1,074         1,074
Cash dividends on common stock (in dollars per share) (785)       (785)  
Stock-based compensation 81   81      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   10,735,000        
Issuance of common stock under the Kenvue 2023 Plan, net 77   77      
Purchase of treasury stock (in shares)   (5,666,000)   5,666,000    
Purchase of treasury stock (127)     $ (127)    
Ending balance (in shares) at Jun. 29, 2025   1,918,837,000        
Ending balance at Jun. 29, 2025 10,730 $ 19 16,288 $ (369) (136) (5,072)
Ending balance (in shares) at Jun. 29, 2025       16,874,000    
Beginning balance (in shares) at Mar. 30, 2025   1,918,859,000        
Beginning balance at Mar. 30, 2025 10,053 $ 19 16,201 $ (305) (163) (5,699)
Beginning balance (in shares) at Mar. 30, 2025       14,208,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 420       420  
Other comprehensive loss 627         627
Cash dividends on common stock (in dollars per share) (393)       (393)  
Stock-based compensation 37   37      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   2,644,000        
Issuance of common stock under the Kenvue 2023 Plan, net 50   50      
Purchase of treasury stock (in shares)   (2,666,000)   2,666,000    
Purchase of treasury stock (64)     $ (64)    
Ending balance (in shares) at Jun. 29, 2025   1,918,837,000        
Ending balance at Jun. 29, 2025 $ 10,730 $ 19 16,288 $ (369) (136) (5,072)
Ending balance (in shares) at Jun. 29, 2025       16,874,000    
Beginning balance (in shares) at Dec. 28, 2025 1,916,115,000 1,916,115,000        
Beginning balance at Dec. 28, 2025 $ 10,765 $ 19 16,348 $ (439) (204) (4,959)
Beginning balance (in shares) at Dec. 28, 2025 20,387,000     20,387,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 930       930  
Other comprehensive loss (395)         (395)
Cash dividends on common stock (in dollars per share) (796)       (796)  
Stock-based compensation 61   61      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   4,126,000        
Issuance of common stock under the Kenvue 2023 Plan, net $ (12)   (12)      
Ending balance (in shares) at Jun. 28, 2026 1,920,241,102 1,920,241,000        
Ending balance at Jun. 28, 2026 $ 10,553 $ 19 16,397 $ (439) (70) (5,354)
Ending balance (in shares) at Jun. 28, 2026 20,387,000     20,387,000    
Beginning balance (in shares) at Mar. 29, 2026   1,919,935,000        
Beginning balance at Mar. 29, 2026 $ 10,608 $ 19 16,362 $ (439) (128) (5,206)
Beginning balance (in shares) at Mar. 29, 2026       20,387,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 456       456  
Other comprehensive loss (148)         (148)
Cash dividends on common stock (in dollars per share) (398)       (398)  
Stock-based compensation 32   32      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   306,000        
Issuance of common stock under the Kenvue 2023 Plan, net $ 3   3      
Ending balance (in shares) at Jun. 28, 2026 1,920,241,102 1,920,241,000        
Ending balance at Jun. 28, 2026 $ 10,553 $ 19 $ 16,397 $ (439) $ (70) $ (5,354)
Ending balance (in shares) at Jun. 28, 2026 20,387,000     20,387,000